ACA
Overvalued by 31.2% based on the discounted cash flow analysis.
Market cap | $4.39 Billion |
---|---|
Enterprise Value | $5.98 Billion |
Dividend Yield | $0.2 (0.222172850477672%) |
Earnings per Share | $1.92 |
Beta | 1.01 |
Outstanding Shares | 48,700,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 56.13 |
---|---|
PEG | -141.05 |
Price to Sales | 1.7 |
Price to Book Ratio | 1.8 |
Enterprise Value to Revenue | 2.3 |
Enterprise Value to EBIT | 38.24 |
Enterprise Value to Net Income | 76 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.72 |
No data
No data